All In Biotech

Drug Trial Radar · NCT05156281

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,007 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,007

Actual

Start

Dec 13, 2021

Primary completion

Jul 22, 2026

Study completion Oct 30, 2030

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Dec 14, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Conditions

  • Relapsing Multiple Sclerosis

Interventions

  • RemibrutinibDrug

    tablet taken orally

  • TeriflunomideDrug

    capsule taken orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized relapse rate (ARR) of confirmed relapses [Core Part]Time frame: From Baseline, up to 30 months

Locations

223 sites in 27 countries. Site status is shown where the registry gives one.

  • Ctr for Neurology and Spine

    Phoenix, Arizona

  • Vladimir Royter MD APMC

    Hanford, California

  • VA Greater LA Healthcare System

    Los Angeles, California

  • Regina Berkovich MD PhD Inc

    West Hollywood, California

  • CU Anschutz Med Campus

    Aurora, Colorado

  • Colorado Neurological Research PC

    Denver, Colorado

  • New England Institute for Clinical Research

    Stamford, Connecticut

  • Georgetown University Hospital Research

    Washington D.C., District of Columbia

  • Georgetown University Hospital

    Washington D.C., District of Columbia

  • Nova Clinical Research LLC

    Bradenton, Florida

  • University of Florida

    Gainesville, Florida

  • Memorial Healthcare System

    Hollywood, Florida

  • Neurology Associates PA

    Maitland, Florida

  • Gables Neurology

    Miami, Florida

  • UM Department Of Neurology

    Miami, Florida

  • Aqualane Clinical Research

    Naples, Florida

  • Advent Health Orlando

    Orlando, Florida

  • Humanity Clinical Research

    Pembroke Pines, Florida

  • Emerald Coast Neurology

    Pensacola, Florida

  • Brain and Spine Institute

    Port Orange, Florida

  • Vero Beach Neurology

    Vero Beach, Florida

  • Conquest Research

    Winter Park, Florida

  • Methodist Neuroscience Institute

    Merrillville, Indiana

  • University of Kansas Hospital

    Kansas City, Kansas

  • Baptist Physicians Lexington

    Nicholasville, Kentucky

  • Ochsner Clinic Foundation

    New Orleans, Louisiana

  • Clinre Comprehensive Neurology

    Frederick, Maryland

  • Tufts Medical Center

    Boston, Massachusetts

  • Kansas City VA Medical Center

    Kansas City, Missouri

  • South Shore Neurologic Associates

    Patchogue, New York

  • University Of NC At Chapel Hill

    Chapel Hill, North Carolina

  • Piedmont HealthCare

    Charlotte, North Carolina

  • The Boster Ctr for MS

    Columbus, Ohio

  • Neurology Diagnostics Inc

    Dayton, Ohio

  • Penn State Hershey Medical Center

    Hershey, Pennsylvania

  • Premier Neurology

    Greenville, South Carolina

  • Metrolina Neurological Associates PA

    Old Point Station, South Carolina

  • Sibyl Wray MD Neurology PC

    Knoxville, Tennessee

  • Carum Research

    Dallas, Texas

  • Med Research Inc

    El Paso, Texas

Showing 40 of 223 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.